Status:
RECRUITING
Optimized MRI of Patients With Hip Arthroplasty
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Radiological Society of North America
ISS, Inc.
Conditions:
Hip Arthropathy
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization ...
Detailed Description
Twenty participants with symptomatic primary total hip arthroplasty will be imaged with both methods. The results of the two methods will be compared in reference to the size of the artifact-degraded ...
Eligibility Criteria
Inclusion
- Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
- Referred for MRI examination at the discretion of the treating physician
- Provision of signed and dated informed consent form
- No metal hardware in the body including contralateral hip arthroplasty
- No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices
Exclusion
- History of revision hip arthroplasty
- Pregnancy (self-reported, or self-suspected)
- Hip arthroplasty surgery within one year of enrollment
- Clinical indication to administer intravenous contrast material during MRI
Key Trial Info
Start Date :
August 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04875884
Start Date
August 11 2022
End Date
December 30 2027
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Radiology - Center for Biomedical Imaging
New York, New York, United States, 10017